Results 171 to 177 of about 17,802 (177)

Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod

Multiple Sclerosis and Related Disorders, 2018
Raed Alroughani, Eugenio Pucci, Yara Dadalti Fragoso   +2 more
exaly  

Fingolimod reduces cerebral lymphocyte infiltration in experimental models of rodent intracerebral hemorrhage

Experimental Neurology, 2013
Yu Hasegawa, Richard E Hartman, Paul R Krafft   +2 more
exaly  

Experience with fingolimod in clinical practice

International Journal of Neuroscience, 2015
Jeffrey A Cohen, Daniel Ontaneda, Carrie M Hersh   +2 more
exaly  

Vagomimetic Effects of Fingolimod: Physiology and Clinical Implications

CNS Neuroscience and Therapeutics, 2014
Gianluca Botto
exaly  

Fingolimod alters inflammatory mediators and vascular permeability in intracerebral hemorrhage

Neuroscience Bulletin, 2015
Kristofer Wood, Ya-Ping Yan, Ying Fu
exaly  

Population Pharmacokinetics of Fingolimod Phosphate in Healthy Participants

Journal of Clinical Pharmacology, 2012
François Mercier, Olivier J David, Robert L Schmouder   +2 more
exaly  

Withdrawal of fingolimod treatment for relapsing–remitting multiple sclerosis: report of six cases

Multiple Sclerosis Journal, 2012
Bahia Hakiki, Emilio Portaccio, Maria Pia Amato   +2 more
exaly